Accession Number: | 0000899243-21-023408 |
Date: | 2021-06-10 |
Issuer: | CLOVIS ONCOLOGY, INC. (CLVS) |
Original Submission Date: |
MCKINLEY EDWARD J
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY, SUITE 100
BOULDER, CO 80301
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 5.97 | 2021-06-10 | deemed execution date | A | 42,223 (a) | 2031-06-10 | common stock 42,223 | $5.97 | 42,223 | direct |
ID | footnote |
---|---|
f1 | the options shall vest on the one-year anniversary of the date of grant. |